Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Codexis, California Institute of Technology deal

Codexis received an exclusive, worldwide license

Read the full 64 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE